Cannonau is a shell company with no employees, no revenue, and no operating business. The company's stated plan is to develop and sell CBD products using nanotechnology to improve bioavailability across a range of consumer products, though Cannonau has not described how it would manufacture, distribute, sell, or fund these products. Cannonau has pivoted its stated business model multiple times since incorporation in 2007, moving from destination wedding travel, to alternative energy, to CBD products in 2019, without ever establishing an operating business in any of these areas.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →